Citadel Advisors - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 31 filers reported holding VIVOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$7,191
-23.9%
14,100
-49.1%
0.00%
Q1 2023$9,448
-55.5%
27,700
-47.5%
0.00%
Q4 2022$21,230
-52.8%
52,809
-24.0%
0.00%
Q3 2022$45,000
+60.7%
69,442
+224.5%
0.00%
Q2 2022$28,000
-50.9%
21,400
+0.5%
0.00%
Q1 2022$57,000
-83.9%
21,300
-86.4%
0.00%
Q4 2021$353,000
-50.8%
156,663
-11.7%
0.00%
Q3 2021$717,000
+582.9%
177,519
+1020.3%
0.00%
Q1 2021$105,00015,8460.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 201,704$81,0850.04%
PERKINS CAPITAL MANAGEMENT INC 52,000$210.02%
Wealth Alliance Advisory Group, LLC 26,249$10,5520.00%
Apexium Financial, LP 40,667$16,3480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3,600$1,4470.00%
GEODE CAPITAL MANAGEMENT, LLC 201,941$810.00%
STATE STREET CORP 91,300$36,7020.00%
TOTH FINANCIAL ADVISORY CORP 200$800.00%
MORGAN STANLEY 1,400$5630.00%
View complete list of VIVOS THERAPEUTICS INC shareholders